Reuters logo
BRIEF-Mylan receives tentative approval from U.S. FDA for "TLE400" under PEPFAR
March 20, 2017 / 5:22 PM / 8 months ago

BRIEF-Mylan receives tentative approval from U.S. FDA for "TLE400" under PEPFAR

March 20 (Reuters) - Mylan NV:

* Mylan receives tentative approval for “TLE400” under PEPFAR

* TLE400 will be available in developing countries as a first-line regimen for people being treated for HIV/AIDS

* Receipt of tentative approval from U.S. FDA under U.S. President’s Emergency Plan for AIDS Relief for NDA for TLE400 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below